SCHEMBL28800067

SCHEMBL28800067

CC(C)c1ccc(C=CCS(=O)(=O)n2c(Cc3ccc(C(=O)O)cc3)cc3cc(C(F)(F)F)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 4/20 0.40
▸ PPARG P37231 7/20 0.38
▸ PPARA Q07869 6/20 0.38
▸ PPARD Q03181 5/20 0.38
▸ SRD5A2 P31213 1/20 0.36
▸ PTGER4 P35408 5/20 0.36
▸ PTGDR Q13258 1/20 0.36
▸ PTGER2 P43116 1/20 0.35
▸ CCR2 P41597 1/20 0.35
▸ DHCR7 Q9UBM7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27867715 0.91 RORC (0.40) RORCPPARGPPARAPPARDSRD5A2
SCHEMBL27936027 0.91 PPARG (0.39) RORCPPARGPPARAPPARDSRD5A2
SCHEMBL27884298 0.90 PPARG (0.36) RORCPPARGPPARAPPARDCCR2
SCHEMBL27884217 0.89 RORC (0.40) RORCPPARGPPARAPPARDSRD5A2
SCHEMBL28800059 0.89 PPARG (0.36) RORCPPARGPPARAPPARDPTGER4
SCHEMBL27867734 0.89 CCR2 (0.39) RORCPPARGPPARAPPARDPTGER4
SCHEMBL27936053 0.89 RORC (0.38) RORCPPARGPPARAPPARDSRD5A2
SCHEMBL28797215 0.88 DHCR7 (0.41) PPARGPPARAPPARDDHCR7
SCHEMBL27884197 0.88 PTPN1 (0.43) RORCPPARGPPARAPPARDSRD5A2
SCHEMBL28946335 0.87 PPARG (0.36) RORCPPARGPPARAPPARDCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103554006-A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease FOURNIER LAB SA 2014-02-05 — — CN disclosed
CN-102596906-A Use of indole derivatives as NURR-1 activators as agents for the treatment of Parkinson's disease FOURNIER LAB SA 2012-07-18 — — CN disclosed
Send feedback